« Return to News | Awards & Advancement

Olivier Brandicourt appointed chairman of Bayer HealthCare

Tuesday, October 1, 2013 11:00 AM

Olivier Brandicourt has been appointed chairman of the board of management of Bayer HealthCare and member of the Bayer executive council effective Nov. 1. Since March, professor Wolfgang Plischke has led Bayer HealthCare on an interim basis in addition to his existing duties as a Bayer board member.

Brandicourt has 25 years of international experience in the pharmaceutical industry, including executive responsibilities in France, the U.S., Canada and the U.K. He has been a member of the executive leadership team of Pfizer for the last three years. Previously, he was president and general manager of the emerging markets and established products business units. Before that he held senior operational positions as president of the global specialty business unit, and until 2012 he was head of the global primary care business unit. He has held senior regional and country management positions at Pfizer and positions in medical and marketing at Warner-Lambert/Parke-Davis.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.